Hemoperfusion as COVID-19 treatment might improve the survival odds of patients on dialysis, a study suggests. Hemoperfusion treatment may decrease the risk of dying from COVID-19 in patients on ...
Hemoperfusion Complete treatments directly on the blood or by treating the plasma coming from a centrifuge. AFERsmart is a compact and complete, easy to use equipment: ...
The study by Cruz et al. was stopped early because of decreased mortality in the hemoperfusion treated group, as assessed by a Cox proportional hazards regression survival model. 9 However, from ...
Dr. John Kellum, Chief Medical Officer of Spectral, noted, “Despite a lower enrollment rate for October we continue to see strong performance across trial sites for screening. Our sites are eager to ...
The animals were connected to an extracorporeal hemoperfusion circuit (see below) and treated either with continuous venovenous hemofiltration with the RAD or with hemofiltration and a control ...
(“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 ...
The OSCAR study is a Prospective Single-Arm Feasibility Trial to evaluate the initial safety and signals of efficacy by determining the ability of the ONCObind Procedure Hemoperfusion Filter to ...
Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A ...
DrugSorb™-ATR is an FDA Breakthrough Device eligible for priority review with an FDA decision anticipated in 2025PRINCETON, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation ...